Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Red cell distribution width increased? 51 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Red cell distribution width increased have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 0.2% of all adverse event reports for INFLIXIMAB-DYYB.

51
Reports of Red cell distribution width increased with INFLIXIMAB-DYYB
0.2%
of all INFLIXIMAB-DYYB reports
3
Deaths
23
Hospitalizations

How Dangerous Is Red cell distribution width increased From INFLIXIMAB-DYYB?

Of the 51 reports, 3 (5.9%) resulted in death, 23 (45.1%) required hospitalization.

Is Red cell distribution width increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 51 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703)

What Other Drugs Cause Red cell distribution width increased?

CLOZAPINE (439) METHOTREXATE (210) ALEMTUZUMAB (202) RITUXIMAB (198) PREDNISONE (178) PALBOCICLIB (171) ADALIMUMAB (144) METHYLPREDNISOLONE (123) ECULIZUMAB (110) TOCILIZUMAB (108)

Which INFLIXIMAB-DYYB Alternatives Have Lower Red cell distribution width increased Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Red cell distribution width increased Reports All Drugs Causing Red cell distribution width increased INFLIXIMAB-DYYB Demographics